UK Regulator Clarifies AI Scribe Classification Under Medical Device Rules
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is weighing in on a growing question within the healthcare technology sector: whether AI-powered medical scribes should be classified as medical devices.
AI scribes are software tools that listen to conversations between clinicians and patients, automatically generating clinical notes, documentation, and other records. Their adoption has accelerated in recent years as healthcare systems look to reduce administrative burden on physicians.
The core issue before the regulator is determining whether these tools, which directly influence the medical record and potentially patient care decisions, cross the threshold into medical device territory under existing UK law. If classified as medical devices, AI scribes would face stricter requirements around validation, clinical evidence, and post-market surveillance.
The MHRA's guidance could shape how developers design and market these products, and how NHS trusts and other UK healthcare providers implement them. Industry observers note that clear regulatory classification helps create a level playing field while ensuring patient safety isn't compromised by software that materially influences clinical decision-making.